You searched for viral vector - Page 3 of 53

News and Trends 25 Feb 2016

High Quality Grade plasmids for a better gene therapy

…momentum thanks to the development of safe viral vectors based on adeno-associated viruses (AAV). AAV are preferred to other approaches for gene therapy as they cause no viral disease symptoms…

February 25, 2016 - 4 minutesmins - By Joachim Eeckhout

The crucial role of GS-CHO innovation in biopharmaceutical progress

…challenges is optimizing the expression vector DNA. Innovative approaches to expression vector design, including the use of novel engineered components, are needed to meet industry challenges head on. “When GS-CHO…

September 3, 2024 - 8 minutesmins - By Alexander Burik

News and Trends 16 Apr 2020

Irish Biotech Raises €18M to Develop Non-Viral Cell Therapy Technology

The Irish company Avectas has closed a Series C round to develop cell therapies that don’t need viral vectors — a common bottleneck in cell therapy manufacturing. The fundraise of…

April 16, 2020 - 2 minutesmins - By Jonathan Smith

News and Trends 21 Jul 2016

Former uniQure and Evotec CEO pushes new viral candidate into Clinical Trials

Hookipa is starting its first clinical trial for a vaccine against human cytomegalovirus. This is the leading candidate of its platform for novel viral vectors, which promises to yield better…

July 21, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 28 Jul 2022

AGC Biologics announces gene therapy partnership with Altheia Science

…global cell and gene industry, working with virtually any cell type and lentiviral, retroviral and adeno‐associated viral vectors. Life-changing treatments JB Agnus, chief business officer of AGC Biologics said: “We…

July 28, 2022 - 2 minutesmins - By Liza Laws

Eyevensis Eye Gene Therapy Approval France

News and Trends 11 Apr 2017

France Approves Trials for the First Eye Gene Therapy Free of Viral DNA

Eyevensys has received regulatory approval in France to start clinical trials using eye gene therapy technology that eliminates the need for viral vectors. The French biotech Eyevensys has been cleared…

April 11, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 12 May 2023

Cell and gene therapy company NewBiologix exits stealth with $50M

…technologies and solutions to boost the production and efficacy of viral vectors, rapidly and more cost effectively.” NewBiologix focuses on adeno-associated virus vectors NewBiologix is currently focused on recombinant adeno-associated…

May 12, 2023 - 3 minutesmins - By Jim Cornall

In Depth 5 Jan 2016

Ultimate Review: How Could mRNA Overtake all other Biologicals in Medicine?

…Alpha virus) or non-viral (Liposome or cationic polymer). For mRNA, non viral vector is the big trend. There is also research into new Nanomedicine alternatives to liposome vectors, such as…

January 5, 2016 - 7 minutesmins - By Jerome Topsent

In Depth 3 May 2024

Can emerging new treatments lead the way to cure Duchenne muscular dystrophy?

…overcome the challenges associated with viral vectors. These include efforts to enhance muscle trophism and reduce immune system detection, potentially allowing for redosing in patients previously treated with viral-based therapies….

May 3, 2024 - 10 minutesmins - By Jules Adam

Best in Biotech 22 Apr 2025

Seven biotechs to watch in the hepatitis B space

…company Acuitas Therapeutics. Turning off the viral genetic material is intended to shut down viral transcription and suppress the production of new viral particles. The biotech unveiled preclinical data where…

April 22, 2025 - 10 minutesmins - By Roohi Mariam Peter

With its molecular clamp technology and its lead multivalent vaccine candidate targeting both RSV and hMPV, Vicebio aims to solve unmet medical needs.

News and Trends 23 Sep 2024

Vicebio and its molecular clamp vaccine raise big to tackle respiratory viruses

…to recognize and fight. Molecular clamp technology differs from other vaccine platforms like mRNA or viral vector vaccines in how it delivers antigens. While mRNA vaccines instruct the body’s cells…

September 23, 2024 - 9 minutesmins - By Jules Adam

Best in Biotech 16 Apr 2025

HIV innovation: Six companies developing new treatments in 2025

…viral DNA. EBT-101 is currently in a phase 1/2 clinical trial involving individuals living with HIV who are on stable antiretroviral therapy (ART). In May 2024, Excision reported that the…

April 16, 2025 - 9 minutesmins - By Jules Adam

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: viral vector

High Quality Grade plasmids for a better gene therapy

The crucial role of GS-CHO innovation in biopharmaceutical progress

Irish Biotech Raises €18M to Develop Non-Viral Cell Therapy Technology

Former uniQure and Evotec CEO pushes new viral candidate into Clinical Trials

AGC Biologics announces gene therapy partnership with Altheia Science

France Approves Trials for the First Eye Gene Therapy Free of Viral DNA

Cell and gene therapy company NewBiologix exits stealth with $50M

Ultimate Review: How Could mRNA Overtake all other Biologicals in Medicine?

Can emerging new treatments lead the way to cure Duchenne muscular dystrophy?

Seven biotechs to watch in the hepatitis B space

Vicebio and its molecular clamp vaccine raise big to tackle respiratory viruses

HIV innovation: Six companies developing new treatments in 2025

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!